UK faces risk of becoming a ‘backwater’ supply market for medicines, BGMA manifesto warns
The association, which represents the interests of UK-based manufacturers and suppliers of off-patent generic and biosimilar medicines, has set out a range of policy...
Dr Reddy’s cancer medication Versavo launched in UK markets
It is the company's first biosimilar product to be approved and launched in the UK and is available in strengths of 100mg and 400mg...
Report: NHS faces over £1 billion loss as 85 biologics go off-patent in five years
The NHS is on track to miss out on savings of over a billion pounds as patents for a new lineup of 85 biologics...
‘Use of biosimilar medicines to treat moderate arthritis is hugely significant milestone’
The National Institute for Health and Care Excellence (NICE)'s decision to recommend the use of biosimilar medicines to treat moderate rheumatoid arthritis is a...